These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17457300)

  • 1. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth.
    Thurston G; Noguera-Troise I; Yancopoulos GD
    Nat Rev Cancer; 2007 May; 7(5):327-31. PubMed ID: 17457300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
    Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
    Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1.
    Pedrosa AR; Trindade A; Fernandes AC; Carvalho C; Gigante J; Tavares AT; Diéguez-Hurtado R; Yagita H; Adams RH; Duarte A
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1134-46. PubMed ID: 25767274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.
    Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G
    Nature; 2006 Dec; 444(7122):1032-7. PubMed ID: 17183313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta-like 4/Notch signaling and its therapeutic implications.
    Yan M; Plowman GD
    Clin Cancer Res; 2007 Dec; 13(24):7243-6. PubMed ID: 18094402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jagged mediates differences in normal and tumor angiogenesis by affecting tip-stalk fate decision.
    Boareto M; Jolly MK; Ben-Jacob E; Onuchic JN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3836-44. PubMed ID: 26153421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
    Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
    Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
    Kuhnert F; Chen G; Coetzee S; Thambi N; Hickey C; Shan J; Kovalenko P; Noguera-Troise I; Smith E; Fairhurst J; Andreev J; Kirshner JR; Papadopoulos N; Thurston G
    Cancer Res; 2015 Oct; 75(19):4086-96. PubMed ID: 26377940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High glucose-induced jagged 1 in endothelial cells disturbs notch signaling for angiogenesis: a novel mechanism of diabetic vasculopathy.
    Yoon CH; Choi YE; Koh SJ; Choi JI; Park YB; Kim HS
    J Mol Cell Cardiol; 2014 Apr; 69():52-66. PubMed ID: 24361239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.
    Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A
    Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
    Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL
    Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling.
    Dong Y; Zhang T; Li J; Deng H; Song Y; Zhai D; Peng Y; Lu X; Liu M; Zhao Y; Yi Z
    PLoS One; 2014; 9(12):e113830. PubMed ID: 25485753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Vascular Notch Ligands Delta-Like Ligand 4 (DLL4) and Jagged1 (JAG1) Have Opposing Correlations with Microvascularization but a Uniform Prognostic Effect in Primary Glioblastoma: A Preliminary Study.
    Qiu XX; Chen L; Wang CH; Lin ZX; Chen BJ; You N; Chen Y; Wang XF
    World Neurosurg; 2016 Apr; 88():447-458. PubMed ID: 26546995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival.
    Donnem T; Andersen S; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
    Cancer; 2010 Dec; 116(24):5676-85. PubMed ID: 20737536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis.
    Benedito R; Roca C; Sörensen I; Adams S; Gossler A; Fruttiger M; Adams RH
    Cell; 2009 Jun; 137(6):1124-35. PubMed ID: 19524514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts.
    Miles KM; Seshadri M; Ciamporcero E; Adelaiye R; Gillard B; Sotomayor P; Attwood K; Shen L; Conroy D; Kuhnert F; Lalani AS; Thurston G; Pili R
    PLoS One; 2014; 9(11):e112371. PubMed ID: 25393540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis.
    Lee D; Kim D; Choi YB; Kang K; Sung ES; Ahn JH; Goo J; Yeom DH; Jang HS; Moon KD; Lee SH; You WK
    MAbs; 2016 Jul; 8(5):892-904. PubMed ID: 27049350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-dependent Notch signaling in vascular formation.
    Kume T
    Adv Exp Med Biol; 2012; 727():210-22. PubMed ID: 22399350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis.
    Ridgway J; Zhang G; Wu Y; Stawicki S; Liang WC; Chanthery Y; Kowalski J; Watts RJ; Callahan C; Kasman I; Singh M; Chien M; Tan C; Hongo JA; de Sauvage F; Plowman G; Yan M
    Nature; 2006 Dec; 444(7122):1083-7. PubMed ID: 17183323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis.
    Oon CE; Harris AL
    Biochem Soc Trans; 2011 Dec; 39(6):1612-8. PubMed ID: 22103496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.